The University of Texas at Arlington · EngineeringNanoparticle Therapeutics Lab
Kytai Truong Nguyen · Arlington, Texas
Research Focus
Dr. Kytai Truong Nguyen's lab at the University of Texas Arlington focuses on developing innovative nanoparticles to treat peripheral arterial disease (PAD), a condition that severely restricts blood flow in the legs, particularly affecting elderly patients. The lab aims to create biodegradable nanoparticles that not only deliver therapeutic agents to promote blood vessel formation but also allow for non-invasive imaging to track treatment progress. Through their research, they hope to provide a new, effective treatment method for PAD that overcomes the limitations of existing therapies.
nanoparticlesperipheral arterial diseaseangiogenesisbiodegradable materialsphotoacoustic imagingfluorescent imagingtherapeutic deliveryischemiacell protection
Research Aims
3AIM 01Synthesize and characterize biodegradable dual-modal imaging nanoparticles.
AIM 02Formulate and analyze nanoparticles loaded with therapeutic agents for cell protection.
AIM 03Evaluate the effectiveness of nanoparticles in treating PAD using in vivo animal models.
Skills the Lab Values
nanoparticle synthesisdual-modal imagingbiomedical engineeringanimal modelsphotoluminescent polymerstissue engineeringfluorescence microscopyphotoacoustic microscopyformulation analysis
Output against the department
Publications219top 43% of dept.119th of 278
this lab
most publishedleast published
Citations8.6ktop 44% of dept.121st of 278
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.